Arcturus Therapeutics Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +232.1% | -36.2% | +21.2% | +32.0% | -54.1% | +29.6% | +1,564.8% | -23.3% | -12.3% | -51.4% | |
| – | – | – | – | – | +476.5% | +39.5% | +4,042.0% | +91.0% | +72.5% | +210.6% | -17.7% | -97.9% | +19.9% | -14.6% | |
| – | – | – | – | – | +230.0% | -37.3% | -109.8% | – | -323.2% | – | +1,564.8% | -23.3% | -12.3% | -53.6% | |
| – | -55.1% | +763.8% | +255.3% | -46.4% | +36.6% | -13.4% | +6.7% | +98.1% | +72.0% | +200.4% | -15.0% | +30.0% | +1.6% | -42.5% | |
| – | -67.2% | +372.0% | +81.1% | -14.5% | +7.3% | +41.3% | +171.8% | -38.5% | +83.4% | +78.5% | +11.1% | +14.8% | -0.1% | -12.8% | |
| – | -61.6% | +585.5% | +221.5% | -40.4% | +27.8% | -6.7% | +59.9% | +23.3% | -45.8% | +756.8% | -10.1% | +21.9% | -0.8% | -40.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -742.2% | – | – | |
| – | +81.8% | +146.3% | -99.0% | +12,450.0% | +17.5% | -49.2% | +24.0% | +359.1% | -2.7% | +221.8% | +12.2% | -74.4% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -362.0% | – | – | |
| – | +209.5% | -6.2% | -127.9% | – | +43.1% | -98.6% | +21,100.0% | -227.4% | – | – | -59.4% | +41.7% | -100.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -417.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -259.3% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.